Atlas Trials

Revance Therapeutics, Inc.

29 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Revance Therapeutics, Inc.

RecordFirmDate
Phase 2a Study of DaxibotulinumtoxinA-lanm for Injection in Dynamic Forehead Lines and Glabellar Lines (NCT06411002)Revance Therapeutics, Inc.2024-04-08
Teosyal RHA® Histology and Intradermal Implantation Evaluation Study (NCT04846530)Revance Therapeutics, Inc.2021-08-20
Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Upper Facial Lines (NCT04259086)Revance Therapeutics, Inc.2019-12-06
Efficacy and Safety of Increasing Doses of DaxibotulinumtoxinA for Injection (DAXI for Injection) in the Treatment of Moderate or Severe Lateral Canthal Lines (NCT03911102)Revance Therapeutics, Inc.2019-03-11
Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Forehead Lines (Frontalis) (NCT03786770)Revance Therapeutics, Inc.2019-01-24
DaxibotulinumtoxinA for Injection for the Treatment of Plantar Fasciitis (NCT03825315)Revance Therapeutics, Inc.2018-12-31
Efficacy and Safety of DaxibotulinumtoxinA for Injection for the Treatment of Adult Upper Limb Spasticity (NCT03821402)Revance Therapeutics, Inc.2018-12-12
Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-OLS) (NCT03617367)Revance Therapeutics, Inc.2018-09-05
Single Treatment of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-1) (NCT03608397)Revance Therapeutics, Inc.2018-06-20

Track Revance Therapeutics, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.